Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,114.2
-12.0 (-0.38%)

 

  • STI Straits Times Index
    3,114.2
    -12.0 (-0.38%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    -3.4 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,719.6
    -128.9 (-0.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,938.1
    -39.2 (-1.32%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,191.9
    10.9 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 937.3M
  • Value: 879.2M
  • Rise: 114
  • Fall: 160
  • Unch: 558

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.002-
Rex Intl0.093+0.005
ThaiBev0.900+0.025
Genting Sing0.915-0.010
Spackman0.016-
YZJ Shipbldg SGD0.940-0.010
Y Ventures0.112+0.001
AEM1.280+0.020
KLW0.003-
Singapore-eDev0.045-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,089.5 -67.3
HSI 26,719.6 -128.9
HSCEI 10,540.0 -48.1
Jakarta 6,191.9 +10.9
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

22ND CENTURY GROUP INC 22ND CENTURY GROUP
Updated on 18 Oct 2019 (End of trading day)
Last (USD): 2.060 Change: +0.060 High: 2.075 Remarks: -
Change (%): +3.00 Low: 1.980
Open 1.980 Yesterday's Close 2.0
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 731,526 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.07753 Trailing EPS (USD) e -0.12387 NAV (USD) b 0.6064
PE a - Trailing PE f - Price / NAV b 3.3971
Dividend (USD) d - Cash In Hand (USD) g 0.0085 Issued & Paid-up Shares c 125,664,000
Dividend Yield (%) d - Price / Cash In Hand g 242.353 Treasury Shares h -
Beta - 75 Daysi 1.866 R-Squared - 75 Days(%)i 10.08 Market Cap (M) 211.686
Beta - 500 Daysi 1.350 R-Squared - 500 Days (%)i 5.77 Enterprise Value (M) 166.582
Piotroski F Score 0 Exchange Code XXII Par Value ( $ ) n.a.
52 Weeks Volatility (%) 66.72 Free Float (%) 94.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 22ND CENTURY GROUP INC NYSE American 211.686 - - 3.3971 -
Industry Biotechnology NYSE American 74.824 - - 2.6295 -
Local Peer PFENEX INC NYSE American 217.643 - - 4.2007 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 146.321 - 4.712 1.0969 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 129.766 - - 57.1429 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 127.177 3.555 3.555 1.2649 -
Local Peer NANOVIRICIDES INC NYSE American 124.883 - - 11.7857 -
Local Peer CEL-SCI CORP NYSE American 73.288 - - 63.9251 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 64.123 - - 2.0818 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 51.171 - - 10.0504 -
Local Peer IBIO INC NYSE American 48.312 - - 19.6415 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 40.332 - - 1.7823 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 31.183 - - 0.9619 -
Local Peer ORAGENICS INC NYSE American 21.863 - - 1.2206 -
Other Local Peers ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 121,571.387 14.483 15.277 11.2628 2.734
Global Peer GILEAD SCIENCES INC NASDAQ 82,205.269 15.070 13.804 3.6348 3.556
Global Peer CSL ASX 113,904.993 42.456 42.456 15.2216 1.057
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CELGENE CORP NASDAQ 72,964.886 18.034 13.843 7.2595 -
Global Peer ILLUMINA INC NASDAQ 45,487.680 55.070 48.494 10.5004 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,297.278 21.607 20.450 8.9344 -
Global Peer BIOGEN INC NASDAQ 40,589.407 9.161 7.667 3.1336 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,989.185 13.496 15.943 3.3815 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,077.029 73.028 21.527 4.8614 0.821
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), GENSCRIPT BIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), COHERUS BIOSCIENCES INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), POLYNOVO LIMITED (ASX), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), VIVA BIOTECH (HKEx), FATE THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), ALECTOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), HAOHAI BIOTEC (HKEx), EPIZYME INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), INTREXON CORP (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MESOBLAST LTD (ASX), ZIOPHARM ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), CHEMOCENTRYX INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ASCLETIS-B (HKEx), REPLIMUNE GROUP INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), ESSEX BIO-TECH (HKEx), SYNTHORX INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DERMIRA INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), XBIOTECH INC (NASDAQ), MERUS B V (NASDAQ), KADMON HLDGS INC (NYSE), PERSONALIS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), NEXT SCIENCE LTD (ASX), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), LEE'S PHARM (HKEx), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARDELYX INC (NASDAQ), TELIX PHARMACEUTIC (ASX), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), GERON CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), ATHERSYS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AFFIMED N V (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BBI LIFE SCI (HKEx), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), IMV INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PHYLOGICA LIMITED (ASX), APTOSE BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), CHIMERIX INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), VERASTEM INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CURIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), PORT (SET), ORGENESIS INC (NASDAQ), COHBAR INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMUGENE LIMITED (ASX), NEWLINK GENETICS CORP (NASDAQ), VERMILLION INC (NASDAQ), CT ENTERPRISE (HKEx), CIDARA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ORTHOCELL LIMITED (ASX), VASCULAR BIOGENICS LTD (NASDAQ), INMUNE BIO INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), IVERIC BIO INC (NASDAQ), BIONOMICS LTD (ASX), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MEMPHASYS LTD (ASX), SAVARA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOCARDIA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BIOSINO BIO-TEC (HKEx), ALIMERA SCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), MICROBOT MEDICAL INC (NASDAQ), OCUGEN INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), BIOCEPT INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), AEVI GENOMIC MEDIC (NASDAQ), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), REGENEUS LTD (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ADALTA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), VAXART INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRECIPIO INC (NASDAQ), TOCAGEN INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), Suntar Eco-City^ (SGX), DARE BIOSCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CELLMID LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), HAO WEN HLDGS (HKEx), ADVAXIS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MGRC (Bursa), MEDIBIO LIMITED (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), MEGASUN (Bursa), ANATARA LIFESCIENCES LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), CCP TECHNOLOGIES LTD (ASX), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), NANOLLOSE LTD (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.020
+0.98 %
10 Days --0.130
-5.94 %
20 Days --0.300
-12.71 %
Medium Term Return 3 Months -+0.130
+6.74 %
6 Months -+0.190
+10.16 %
1 Year --0.820
-28.47 %
Long Term Return 2 Years --0.600
-22.56 %
3 Years -+0.870
+73.11 %
5 Years -+0.040
+1.98 %
Annualised Return Annualised --
+0.39 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.120 - 3.115 Change From 1 Year Low +0.940 % Change From 1 Year Low (%) +83.93
Change From 1 Year High -1.055 % Change From 1 Year High (%) -33.87
2 Years Range 1.120 - 4.440 Change From 2 Years Low +0.940 % Change From 2 Years Low (%) +83.93
Change From 2 Years High -2.380 % Change From 2 Years High (%) -53.60
5 Years Range 0.560 - 4.440 Change From 5 Years Low +1.500 % Change From 5 Years Low (%) +267.86
Change From 5 Years High -2.380 % Change From 5 Years High (%) -53.60
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2019 1.980 2.075 1.980 2.060 731,526 -
17 Oct 2019 2.000 2.040 1.980 2.000 481,885 -
16 Oct 2019 2.020 2.060 1.990 1.990 729,802 -
15 Oct 2019 1.990 2.040 1.960 2.030 605,889 -
14 Oct 2019 2.040 2.040 1.965 1.990 466,657 -
11 Oct 2019 2.090 2.170 2.040 2.040 719,573 -
10 Oct 2019 2.100 2.148 2.060 2.060 725,365 -
09 Oct 2019 2.090 2.130 2.060 2.120 855,904 -
08 Oct 2019 2.100 2.170 2.060 2.080 821,399 -
07 Oct 2019 2.180 2.220 2.090 2.120 854,666 -
04 Oct 2019 2.060 2.220 2.060 2.190 1,000,848 -
03 Oct 2019 2.110 2.120 1.960 2.070 649,166 -
02 Oct 2019 2.120 2.150 1.930 2.130 1,491,582 -
01 Oct 2019 2.280 2.300 2.090 2.150 1,281,925 -
30 Sep 2019 2.380 2.430 2.250 2.260 981,023 -
27 Sep 2019 2.430 2.460 2.360 2.400 1,279,249 -
26 Sep 2019 2.330 2.400 2.280 2.400 1,275,995 -
25 Sep 2019 2.220 2.310 2.130 2.310 1,023,031 -
24 Sep 2019 2.260 2.310 2.200 2.230 827,400 -
23 Sep 2019 2.380 2.380 2.250 2.270 1,026,927 -
20 Sep 2019 2.250 2.375 2.235 2.360 1,427,817 -
19 Sep 2019 2.230 2.300 2.200 2.250 655,391 -
Summary
Current 2 Weeks
(07 Oct 2019 to 18 Oct 2019)
2.180 2.220 1.960 2.060 6,992,666 -
Previous 2 Weeks
(23 Sep 2019 to 04 Oct 2019)
2.380 2.380 1.960 2.190 10,837,146 -
4 Weeks from
(23 Aug 2019 to 20 Sep 2019)
1.970 2.220 1.920 2.360 20,921,027 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.